The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

Finckh, Axel; Neto, D; Iannone, F; Loza, E; Lie, E; van Riel, P; Hetland, M L; Pavelka, K; Gottenberg, J E; Canhão, H; Mariette, X; Turesson, C

doi:10.1136/rmdopen-2014-000040

Scientific article

English

The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

ContributorsFinckh, Axel; Neto, D; Iannone, F; Loza, E; Lie, E; van Riel, P; Hetland, M L; Pavelka, K; Gottenberg, J E; Canhão, H; Mariette, X; Turesson, C

Published inRMD open, vol. 1, no. 1, e000040

Publication date2015

Abstract

There are substantial differences in accessibility to biological disease modifying antirheumatic drugs (bDMARDs) across countries. The objective of this study was to analyse the impact of patient demographics, disease characteristics and gross domestic product (GDP) on abatacept (ABA) retention in patients with rheumatoid arthritis (RA) treated in clinical practice.

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Mécanisme de l'inflammation articulaire (44)

Citation (ISO format)

FINCKH, Axel et al. The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries. In: RMD open, 2015, vol. 1, n° 1, p. e000040. doi: 10.1136/rmdopen-2014-000040

Article (Published version)

Identifiers

PID : unige:87993
DOI : 10.1136/rmdopen-2014-000040
PMID : 26509062

Journal ISSN2056-5933

428views

218downloads

Creation31/08/2016 10:52:00

First validation31/08/2016 10:52:00

Update time15/03/2023 00:48:20

Status update15/03/2023 00:48:19

Last indexation31/10/2024 17:18:24

Archive ouverte UNIGE

The impact of patient heterogeneity and socioeconomic factors on abatacept retention in rheumatoid arthritis across nine European countries

Technical informations